Pharmafile Logo

Peter Impey

- PMLiVE

Servier cleared to start US trials CAR-T therapy

FDA rules studies of its Pfizer-partnered drug can be resumed

Bristol-Myers Squibb (BMS) building

BMS replaces R&D head in wake of Opdivo setbacks

As Merck & Co’s Keytruda gains the lion’s share of the market

- PMLiVE

Dean Sowman joins Portland Health

He moves from MHP Communications to take up account director role

Attend our communication strategy workshops in Barcelona

Be sure to sign up for our two multichannel strategy workshops at eyeforpharma Barcelona 2017 (March 14-16th).

Anthill Agency

- PMLiVE

Indigenus agency alliance renames as The Bloc Partners

And commits to operate as a more unified entity

NIHR to pilot ResearchKit app

Will look at how mobile technology can aid clinical research

- PMLiVE

Avelumab costs peg back profit at Merck KGaA

Development of its immuno-oncology product is central to Merck's healthcare plans

- PMLiVE

Lucid expands with launch of new strategic consultancy

Its new company will be led by Duncan Ferguson

Actelion HQ Switzerland

EU nod for Actelion’s skin cancer drug Ledaga

Still need to meet CHMP post-approval requirements

- PMLiVE

Hywel Day joins Napp Pharmaceuticals

Moves from Mundipharma to take up managing director role

- PMLiVE

emotive appoints new medical director

Dr Gill Boucher joins the agency from QuintilesIMS

- PMLiVE

Lucid Group gains further momentum with launch of new Strategic Consultancy

Lucid Group has made an exciting company expansion with the launch of the new Lucid Strategic Consultancy and the appointment of Duncan Ferguson as MD.Duncan Ferguson is highly qualified for...

Lucid Group Communications Limited

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links